A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.

Scientists are exploring smell tests as an early indicator of Alzheimer's risk, detecting brain changes years before memory ...

Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

A new study from Mass General Brigham suggests a blood test may detect early biological signs of Alzheimer’s disease earlier ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Diagnosing Alzheimer’s disease remains a complicated undertaking, in part because several conditions can affect cognition ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental impact ...